Abstract
Hypertension is a well-known risk factor for atherosclerosis, but the molecular mechanisms that link elevated blood pressure to atherosclerosis progression remain uncertain. The interactions of mechanical forces and cells of the vasculature are relevant to many cardiovascular diseases. Once a monocyte infiltrates a tissue, it establishes extracellular matrix contacts and is subjected to deformation through those contacts. Macrophages participate in atherogenesis and commonly localize at sites of coronary plaque rupture. Although macrophages may be subjected to excess mechanical stress in these conditions, how biomechanical forces affect macrophage function remains incompletely defined. Recent work demonstrates that human monocytes / macrophages respond to mechanical deformation with selective augmentation of matrix metalloproteinases and induction of immediateearly genes. In human monocytes / macrophages and THP-1 cells, biomechanical strain can induce expression of the class A scavenger receptor, an important lipoprotein receptor in atherogenesis. In addition, DNA microarray analysis reveals that cyclic mechanical strain induces only a few genes ( > 2.5-fold), including interleukin-8 and IEX- 1 in THP-1 cells. Thus, biomechanical deformation of monocytes / macrophages contributes to degradation of extracellular matrix, monocyte differentiation, and promotion of atherosclerosis. These findings suggest that mechanical stress in vivo, such as hypertension, may play an important role in atherogenesis and instability of coronary-artery plaques through biomechanical effects on vascular macrophages.
Keywords: Monocytes, hypertension, atherosclerosis, metalloproteinases, interleukin
Current Vascular Pharmacology
Title: Role of Mechanical Stress in Monocytes / Macrophages: Implications for Atherosclerosis
Volume: 1 Issue: 3
Author(s): Keiji Yamamoto, Uichi Ikeda and Kazuyuki Shimada
Affiliation:
Keywords: Monocytes, hypertension, atherosclerosis, metalloproteinases, interleukin
Abstract: Hypertension is a well-known risk factor for atherosclerosis, but the molecular mechanisms that link elevated blood pressure to atherosclerosis progression remain uncertain. The interactions of mechanical forces and cells of the vasculature are relevant to many cardiovascular diseases. Once a monocyte infiltrates a tissue, it establishes extracellular matrix contacts and is subjected to deformation through those contacts. Macrophages participate in atherogenesis and commonly localize at sites of coronary plaque rupture. Although macrophages may be subjected to excess mechanical stress in these conditions, how biomechanical forces affect macrophage function remains incompletely defined. Recent work demonstrates that human monocytes / macrophages respond to mechanical deformation with selective augmentation of matrix metalloproteinases and induction of immediateearly genes. In human monocytes / macrophages and THP-1 cells, biomechanical strain can induce expression of the class A scavenger receptor, an important lipoprotein receptor in atherogenesis. In addition, DNA microarray analysis reveals that cyclic mechanical strain induces only a few genes ( > 2.5-fold), including interleukin-8 and IEX- 1 in THP-1 cells. Thus, biomechanical deformation of monocytes / macrophages contributes to degradation of extracellular matrix, monocyte differentiation, and promotion of atherosclerosis. These findings suggest that mechanical stress in vivo, such as hypertension, may play an important role in atherogenesis and instability of coronary-artery plaques through biomechanical effects on vascular macrophages.
Export Options
About this article
Cite this article as:
Yamamoto Keiji, Ikeda Uichi and Shimada Kazuyuki, Role of Mechanical Stress in Monocytes / Macrophages: Implications for Atherosclerosis, Current Vascular Pharmacology 2003; 1 (3) . https://dx.doi.org/10.2174/1570161033476565
DOI https://dx.doi.org/10.2174/1570161033476565 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Endothelial Progenitor Cell Mobilization After Percutaneous Angioplasty Procedure
Current Pharmaceutical Design Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health)
Current Pharmacogenomics and Personalized Medicine Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases
Current Neuropharmacology Lipid Nanoparticles for the Delivery of Active Natural Medicines
Current Pharmaceutical Design Immunization Against Active Ghrelin Using Virus-Like Particles for Obesity Treatment
Current Pharmaceutical Design Best Practice for Atrial Fibrillation Patient Education
Current Pharmaceutical Design Role of Sensory Neurons in Restitution and Healing of Gastric Ulcers
Current Pharmaceutical Design Donepezil May Reduce Insulin-Like Growth Factor-1 (IGF-1) Levels in Alzheimer’s disease
CNS & Neurological Disorders - Drug Targets BHUx: A Patented Polyherbal Formulation to Prevent Hyperlipidemia and Atherosclerosis
Recent Patents on Inflammation & Allergy Drug Discovery Therapeutics Targeting Nogo-A Hold Promise for Stroke Restoration
CNS & Neurological Disorders - Drug Targets Interferon-λ3 as a Predictor of Survival in Hemodialysis Patients.
Current Molecular Medicine Designing Peptidomimetics
Current Topics in Medicinal Chemistry Epidemiology of Ischemic Heart Disease and Diabetes in South Asia: An Overview of the Twin Epidemic
Current Diabetes Reviews Molecular Biology of T-Type Calcium Channels
CNS & Neurological Disorders - Drug Targets Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature
Current Diabetes Reviews Natural Products in Regression and Slowing of Progression of Atherosclerosis
Current Pharmaceutical Biotechnology The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Current Genomics Airway Management in Pediatric Head and Neck Infections
Infectious Disorders - Drug Targets Platelet Function in Inflammatory Diseases: Insights from Clinical Studies
Inflammation & Allergy - Drug Targets (Discontinued) Mitochondria-Targeted Drugs
Current Molecular Pharmacology